Arkolith/Insider Trading/IMVT/Form 4

Venker Eric

Chief Executive Officer, DirectorImmunovant, Inc. (IMVT) · full profile →Form 4 · filed Apr 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$343K
Net Open-Market Flow
-$343K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 2, 2026Sell(S)13K$24.04$308K21K
Apr 2, 2026Sell(S)1K$24.60$35K20K
Apr 1, 2026Option exercise(M)369K$14.46$5.3M369K
Apr 1, 2026Disposed to issuer(D)335K$25.10$8.4M34K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2026Option exercise(M)369K—$01.1M

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001764013-26-000024) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML